Health Innovations (UK) Ltd 06200615 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is Manufacture of Basic Pharmaceutical Products. Digita Accounts Production Advanced 6.30.9574.0 true false true true 06200615 2024-01-01 2024-12-31 06200615 2024-12-31 06200615 core:CurrentFinancialInstruments 2024-12-31 06200615 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 06200615 core:Non-currentFinancialInstruments 2024-12-31 06200615 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 06200615 core:OtherPropertyPlantEquipment 2024-12-31 06200615 bus:SmallEntities 2024-01-01 2024-12-31 06200615 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 06200615 bus:FilletedAccounts 2024-01-01 2024-12-31 06200615 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 06200615 bus:RegisteredOffice 2024-01-01 2024-12-31 06200615 bus:Director4 2024-01-01 2024-12-31 06200615 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 06200615 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 06200615 core:PlantMachinery 2024-01-01 2024-12-31 06200615 core:AllSubsidiaries 2024-01-01 2024-12-31 06200615 core:ParentEntities 2024-01-01 2024-12-31 06200615 core:Subsidiary1 2024-01-01 2024-12-31 06200615 core:Subsidiary1 1 2024-01-01 2024-12-31 06200615 core:Subsidiary1 countries:EnglandWales 2024-01-01 2024-12-31 06200615 core:Subsidiary2 2024-01-01 2024-12-31 06200615 core:Subsidiary2 1 2024-01-01 2024-12-31 06200615 core:Subsidiary2 countries:Hungary 2024-01-01 2024-12-31 06200615 countries:EnglandWales 2024-01-01 2024-12-31 06200615 2023-12-31 06200615 core:OtherPropertyPlantEquipment 2023-12-31 06200615 2023-01-01 2023-12-31 06200615 2023-12-31 06200615 core:CurrentFinancialInstruments 2023-12-31 06200615 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 06200615 core:Non-currentFinancialInstruments 2023-12-31 06200615 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 06200615 core:CostValuation 2023-12-31 06200615 core:OtherPropertyPlantEquipment 2023-12-31 06200615 core:Subsidiary1 1 2023-01-01 2023-12-31 06200615 core:Subsidiary2 1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 06200615

Health Innovations (UK) Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Health Innovations (UK) Ltd

Contents

Balance Sheet

1

Notes to the Financial Statements

2 to 5

 

Health Innovations (UK) Ltd

(Registration number: 06200615)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

1,719,248

1,200,470

Investments

5

425,000

425,000

 

2,144,248

1,625,470

Current assets

 

Stocks

468,329

663,950

Debtors

6

1,501,901

2,090,986

Cash at bank and in hand

 

173

507

 

1,970,403

2,755,443

Creditors: Amounts falling due within one year

7

(1,279,497)

(1,641,345)

Net current assets

 

690,906

1,114,098

Total assets less current liabilities

 

2,835,154

2,739,568

Creditors: Amounts falling due after more than one year

7

(1,819,293)

(1,975,916)

Net assets

 

1,015,861

763,652

Capital and reserves

 

Called up share capital

100

100

Retained earnings

1,015,761

763,552

Shareholders' funds

 

1,015,861

763,652

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 6 August 2025
 

.........................................
Ms Clare Campbell
Director

 

Health Innovations (UK) Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Airedale Business Centre
Millenium Road
Skipton
North Yorkshire
BD23 2TZ

These financial statements were authorised for issue by the director on 6 August 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

10% - 33% on cost

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 65 (2023 - 65).

 

Health Innovations (UK) Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

4

Tangible assets

Plant and machinery
 £

Total
£

Cost or valuation

At 1 January 2024

2,602,859

2,602,859

Additions

701,467

701,467

At 31 December 2024

3,304,326

3,304,326

Depreciation

At 1 January 2024

1,402,389

1,402,389

Charge for the year

182,689

182,689

At 31 December 2024

1,585,078

1,585,078

Carrying amount

At 31 December 2024

1,719,248

1,719,248

At 31 December 2023

1,200,470

1,200,470

5

Investments

2024
£

2023
£

Investments in subsidiaries

425,000

425,000

Subsidiaries

£

Cost or valuation

At 1 January 2024

425,000

Carrying amount

At 31 December 2024

425,000

At 31 December 2023

425,000

 

Health Innovations (UK) Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

2024

2023

Subsidiary undertakings

Vitrition UK Ltd

Unit 26
Victoria Spring Business Park
Wormald Street
Liversedge
West Yorkshire
WF15 6RA

England and Wales

Ordinary

100%

100%

HI Eu k.f.t

Hungary

Ordinary

95%

95%

6

Debtors

Current

Note

2024
£

2023
£

Trade debtors

 

1,025,609

1,302,554

Amounts owed by related parties

8

390,951

390,951

Prepayments

 

45,647

62,481

Other debtors

 

39,694

335,000

   

1,501,901

2,090,986

 

Health Innovations (UK) Ltd

Notes to the Financial Statements for the Year Ended 31 December 2024

7

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Bank borrowings

8,188

8,970

Bank overdrafts

236,154

207,337

HP and finance lease liabilities

270,827

206,011

Trade creditors

398,300

931,419

Taxation and social security

218,357

274,107

Accruals and deferred income

52,644

6,031

Other creditors

95,027

7,470

1,279,497

1,641,345

Creditors: amounts falling due after more than one year

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

10,000

20,000

HP and finance lease liabilities

609,293

455,916

Other borrowings

1,200,000

1,500,000

1,819,293

1,975,916

8

Related party transactions

HI kft

(Subsidiary company)
There were no disclosable transactions during the year. The balance owing from HI kft at 31 December 2024 was £390,951 (2023 - £390,951).

Vitrition (UK) Ltd

(Subsidiary company)
During the year Health Innovations (UK) Ltd made purchases of £Nil (2023 - £Nil) from Vitrition (UK) Ltd. During the year dividend of £200,000 (2023 - £Nil) received from Vitrition (UK) Ltd. The balance owing from Vitrition (UK) Ltd at 31 December 2024 was £Nil (2023 - £Nil).